USA-based startup Pathos develops a platform that utilizes vast oncology data, genomic information, and advanced AI with laboratory environments to re-engineer drug development. The PathOS platform integrates real-world oncology data, patient-derived functional genomic data, and silicon analyses with biological modeling to design optimal clinical trials.